Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) – Early Biomarker for Acute Kidney Injury in Critically Ill Patients

1. Singbartl K, Kellum JA. AKI in the ICU: Definition, Epidemiology, Risk Stratification, and Outcomes. Kidney Int. 2012;81(9):819-25.10.1038/ki.2011.339Search in Google Scholar

2. Cruz DN, Cal M, Garzotto M. Plasma neutrophil gelatinaseassociated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 2010; 36:444-51.10.1007/s00134-009-1711-1Search in Google Scholar

3. Fatemeh G, Faranak K, Esmat G, Rahimipour A, Houshang A, Malihe N. Assessment of Neutrophil gelatinase-associated lipocalin (NGAL) as an early biomarker for detection of renal impairment in hypertensive patients. Journal of Paramedical Sciences. 2014;5:63-6.Search in Google Scholar

4. Flower DR, North AC, Sansom CE. The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta. 2000;1482:9-24.10.1016/S0167-4838(00)00148-5Search in Google Scholar

5. Bolignano D, Donato V, Coppolino G, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Marker of Kidney Damage.American Journal of Kidney Diseases. 2008;52:595-605.10.1053/j.ajkd.2008.01.020Search in Google Scholar

6. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268:10425-32.10.1016/S0021-9258(18)82217-7Search in Google Scholar

7. Devarajan P: Emerging Biomarkers of Acute Kidney Injury. In Ronco C, Bellomo R, Kellum JA: Acute Kidney Injury. ContribNephrol, vol 156. Basel:Karger. 2007, pp 203-12.10.1159/00010208517464129Search in Google Scholar

8. K Mori, K Nakao. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney International. 2007;71:967-70.10.1038/sj.ki.500216517342180Search in Google Scholar

9. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.10.1186/cc5713220644617331245Search in Google Scholar

10. Prowle JR, Leitch A, Kirwan CJ, Forni LG. Positive fluid balance and AKI diagnosis: assessing the extent and duration of ‘creatinine dilution’. Intensive Care Med. 2015;41:160-1.10.1007/s00134-014-3538-725398305Search in Google Scholar

11. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): A new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008;241:89-94.10.1080/00365510802150158252883918569973Search in Google Scholar

12. Perry TE, Muehlschlegel JD, Liu KY. Plasma Neutrophil Gelatinase-Associated Lipocalin and Acute Postoperative Kidney Injury in Adult Cardiac Surgical Patients. AnesthAnalg. 2010;110:1541-7.10.1213/ANE.0b013e3181da938e299984120435938Search in Google Scholar

13. Fielitz AH, Bellomo R, Devarajan P, et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant. 2009;24:3349-54.10.1093/ndt/gfp23419474273Search in Google Scholar

14. Bachorzewska GH, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. Neutrophil gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol. 2006;26:287-92.10.1159/00009396116772710Search in Google Scholar

15. Malyszko J, Bachorzewska GH, Malyszko JS, Dobrzycki S. Could NGAL predict renal function after percutaneous coronary interventions? J Am SocNephrol. 2006;17:406A.Search in Google Scholar

16. Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;6:1639-45.10.1111/j.1600-6143.2006.01352.x16827865Search in Google Scholar

17. Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006;21:856-63.10.1007/s00467-006-0055-016528543Search in Google Scholar

18. Mitsnefes M, Kathman T, Mishra J, et al. Serum NGAL as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol. 2007;22:101-8.10.1007/s00467-006-0244-x17072653Search in Google Scholar

19. Bolignano D, Coppolino G, Campo S, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transpl. 2008;23:414-6.10.1093/ndt/gfm54117893105Search in Google Scholar

20. Bolignano D, Coppolino G, Campo S, et al. Neutrophil gelatinase associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol. 2007;27:373-8.10.1159/00010391217570904Search in Google Scholar

21. Legrand M, Jacquemod A, Gayat E. Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria. Intensive Care Med. 2015;41:68-76.10.1007/s00134-014-3566-325465906Search in Google Scholar

22. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clinical Journal of the American Society of Nephrology. 2009;4:337-44.10.2215/CJN.03530708263760119176795Search in Google Scholar

23. Haase M, Bellomo R, Fielitz AH. Neutrophil gelatinaseassociated lipocalin: a superior biomarker for detection of subclinical acute kidney injury and poor prognosis. Biomarkers Med. 2011;5(4):415-7.10.2217/bmm.11.4921861662Search in Google Scholar

24. Devarajan P. Biomarkers for the early detection of acute kidney injury. Current Opinion in Pediatrics. 2011;23:194-200.10.1097/MOP.0b013e328343f4dd325751321252674Search in Google Scholar

25. Poniatowski B, Malyszko J, Bachorzewska GH, Malyszko JS, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney Blood Press Res. 2009;32:77-80.10.1159/00020898919287180Search in Google Scholar

26. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut. 1996;38:414-20.10.1136/gut.38.3.41413830728675096Search in Google Scholar